ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)

被引：13

作者：

Herrstedt J. ^{[1
,5
]}

Aapro M.S. ^{[2
,5
]}

Roila F. ^{[3
,5
]}

Kataja V.V. ^{[4
,5
]}

机构：

[1] University Hospital Herlev, Dept. of Oncology

[2] Clinique de Genolier, CH-1245 Genolier

[3] Medical Oncology Division, Silvestrini Hospital, 06080 S. Sisto, Perugia

[4] University Hospital of Kuopio, FIN-70211 Kuopio

[5] ESMO Guidelines Task Force, ESMO Head Office, CH-6962 Viganello-Lugano

来源：

ANNALS OF ONCOLOGY | 2005年 / 16卷

关键词：

D O I：

10.1093/annonc/mdi805

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：77 / 79

页数：3

共 3 条

[1] Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines [J].

Gralla, RJ ;

Osoba, D ;

Kris, MG ;

Kirkbride, P ;

Hesketh, PJ ;

Chinnery, LW ;

Clark-Snow, R ;

Gill, DP ;

Groshen, S ;

Grunberg, S ;

Koeller, JM ;

Morrow, GR ;

Perez, EA ;

Silber, JH ;

Pfister, DG .

JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) :2971-2994

[2] Role of neurokinin-1 receptor antagonists in chemotherapy-induced emesis: Summary of clinical trials [J].

Navari, RM .

CANCER INVESTIGATION, 2004, 22 (04) :569-576

[3]

1998, ANN ONCOL, V9, P811

← 1 →